Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Kevzara is an IL-6 only inhibitor. Contraindicative side effects in COVID-19 and suppresses the immune system. Inferior to leronlimab.
Since the patent is good for 20 years this leaves only seven years or so to make hay while the sun shines,
Also, the regular bid price at the time of listing must be $4.00
What is themediaframe.com's track record?
Minimum financials for Nasdaq listing we haven't met yet.
Stockholders’ Equity -$4 million
Net Tangible Assets - $2 million and a 3 year operating history
Working Capital - sufficient for 12 months or a credible revenue plan that would cover 12 months working capital
All achievable with COVID-19 or HIV approval.
No. 6 is amusing "Market Cap: 19.81M"
I think they went on a shoe video shoot in the midst of CoVID-19. Hopefully they haven't succumbed or we'll never know whether L4L shoes are in stock.
As a merged company the activity of L4L would have to be reflected in the RBNW filings as of the date of merger. If it isn't then the RBNW filing would be fraudulent.
It just did - .0012 to .0015. Now sell $200 worth of shares and crash the price back down.
That is if indeed our product works in the manner discussed by Dr.'s Lalezari and Patterson last week.
Been pumping that theory for two years as well
Also, shouldn’t we be getting 3,7 10 day info from patients first enrolled!
With J and J only having 17 billion cash on hand it's unlikely.
It appears that Inventory gets shipped directly to vendors- super smart.
Where's the inventory for L4L? Where is the income?
All you investors have been had.
but BP was talking about how all other meds target only one aspect of the cytokine cascade, unlike Leronlimab.
Your the last person to talk about educated statements.
Fluff News!
How about you tell us now what to expect from today’s call?
You're right GILD should take a hit.
Pretty sure that’s material and would have been reported.
Cry me a river ....
On your mythical trading day 200% from current share price with 20m volume would be $60,000 profit. That would assume that you bought all 20 million shares and it would stay at .003 instead of dropping like a lead weight on the sell off. If you made $600 I would be surprised. Now the only probably is that 200% up is nowhere to be seen.
once the last filings drop and the OTC profile is reporting current at the end of this month or by may 15th
If Gilead was smart they would have made a reasonable offer in 2018. An acceptable offer now would burn through a very large portion of their cash reserves. I don't see offers from any BP coming in before COVID-19 approval and afterwards they won't be able to afford us.
GILD would face shareholder lawsuits and have the Board of Directors and CEO thrown out if they made an appropriate offer.
A quick glance shows that Arcus has anti-PD-1 drugs. Gilead could go head to head with Keytruda. Meanwhile lowering PD-1 is just one of the ways leronlimab fights cancer.
This time around they might offer one cent above share price.
Gilead talked to Cytodyn several years ago and they lowballed us. Since then it seems Gilead thinks they can buy elsewhere to outcompete leronlimab.
What has ATOS done? Announce that they're going to combine two unspecified drugs and bring them to trial. If the shorts want a target ATOS is a much better one.
SCAM alert !!!!!!!
turds
Are you part of the HB crew?
Another drug that does part of what leronlimab does.
My transcription skills aren't bad either.
Also, 1 million WASN’T ordered. He was saying they need the financing to order it.
"We are actually about to have the manufacturing of 1,000,000 vials to be delivered to us from Samsung."
We know Dr. Lalezari was supposed to talk to Dr. Fauci. I'm sure it wasn't for old times sake.
why does there have to be a 7m buyback by today?
Spread the word, it's another potential treatment/cure for Coronavirus.
They've licensed out a technology that may one day produce an antiviral compound. Your posts are pure comedy.
Brain, Nervous System are Affected in 1 in 3 Cases of Severe COVID-19. Strokes, altered consciousness and other neurological issues are relatively common in more serious cases of COVID-19. Among other things - numerous reports emerged that one key sign of infection was a loss of sense of smell, pointing to the virus somehow affecting nerve pathways.